Buys | $0 | 0 | 0 |
Sells | $1,085,146 | 2 | 100 |
Mastrocola Lauren | Principal Accounting Officer | 0 | $0 | 1 | $424,318 | $-424,318 |
Nemiroff Alex | General Counsel and Secretary | 0 | $0 | 1 | $660,827 | $-660,827 |
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential …
Over the last 12 months, insiders at Praxis Precision Medicines, Inc. have bought $0 and sold $1.09M worth of Praxis Precision Medicines, Inc. stock.
On average, over the past 5 years, insiders at Praxis Precision Medicines, Inc. have bought $2.55M and sold $8.67M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 14,500 shares for transaction amount of $25,375 was made by DeSimone Jill (director) on 2023‑10‑05.
2024-11-14 | Sale | Nemiroff Alex | General Counsel and Secretary | 8,239.33 0.0451% | $80.20 | $660,827 | -3.72% | |
2024-11-14 | Sale | Mastrocola Lauren | Principal Accounting Officer | 5,188.34 0.029% | $81.78 | $424,318 | -3.72% | |
2023-10-05 | DeSimone Jill | director | 14,500 0.0118% | $1.75 | $25,375 | +82.67% | ||
2023-06-27 | Souza Marcio | Chief Executive Officer | 10,000 0.0186% | $1.06 | $10,587 | +52.34% | ||
2023-03-24 | MITCHELL DEAN J | director | 50,000 0.0964% | $0.84 | $41,815 | +43.72% | ||
2023-03-24 | Kelly Timothy Edwin | Chief Financial Officer | 8,000 0.0161% | $0.87 | $6,998 | +43.72% | ||
2023-03-23 | Souza Marcio | Chief Executive Officer | 70,001.75 0.1332% | $0.86 | $60,366 | +37.08% | ||
2022-06-16 | Mastrocola Lauren | Principal Accounting Officer | 3,000 0.0065% | $1.93 | $5,775 | +14.95% | ||
2022-06-13 | Nemiroff Alex | General Counsel and Secretary | 7,500 0.0147% | $1.63 | $12,225 | +22.53% | ||
2022-06-09 | Kelly Timothy Edwin | Chief Financial Officer | 10,000 0.0221% | $1.76 | $17,650 | +27.43% | ||
2022-06-08 | Souza Marcio | Chief Executive Officer | 27,000 0.0609% | $1.85 | $49,888 | +23.89% | ||
2022-06-08 | MITCHELL DEAN J | 25,000 0.0551% | $1.81 | $45,188 | +23.89% | |||
2021-10-06 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 400,000 0.8% | $17.50 | $7M | -45.09% | |
2021-10-05 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 23,946 0.0534% | $19.15 | $458,566 | -43.95% | |
2021-10-01 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 22,600 0.0498% | $19.13 | $432,338 | -43.44% | |
2021-08-31 | Kelly Timothy Edwin | Chief Financial Officer | 3,905 0.0086% | $19.48 | $76,069 | -35.35% | ||
2021-08-23 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 352,396 0.7552% | $19.00 | $6.7M | -33.99% | |
2021-08-18 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 3,000 0.0067% | $15.88 | $47,640 | -17.40% | |
2021-08-18 | Souza Marcio | Chief Executive Officer | 9,542 0.021% | $15.79 | $150,668 | -17.40% | ||
2021-08-12 | Sale | BSOF Parallel Master Fund L.P. | 10 percent owner | 10,060 0.0226% | $13.92 | $140,035 | -4.00% |
Nemiroff Alex | General Counsel and Secretary | 10301 0.0511% | $401,004.97 | 1 | 1 | +22.53% |
Mastrocola Lauren | Principal Accounting Officer | 5613 0.0278% | $218,500.70 | 1 | 1 | +14.95% |
Vitorovic Stefan | director | 2939329 14.5776% | $114.43M | 1 | 0 | +1.23% |
MITCHELL DEAN J | director | 75000 0.372% | $2.92M | 2 | 0 | +33.8% |
Kelly Timothy Edwin | Chief Financial Officer | 46416 0.2302% | $1.81M | 3 | 0 | +35.57% |
$3,596,906 | 112 | 13.42% | $635.29M | |
$7,929,017 | 58 | 21.56% | $788.11M | |
$97,176 | 41 | 42.84% | $782.59M | |
$28,907,358 | 35 | 41.41% | $914.6M | |
$61,752,931 | 34 | 14.31% | $749.88M |
Increased Positions | 93 | +66.43% | 5M | +26.98% |
Decreased Positions | 62 | -44.29% | 2M | -12.04% |
New Positions | 38 | New | 625,470 | New |
Sold Out Positions | 11 | Sold Out | 220,454 | Sold Out |
Total Postitions | 171 | +22.14% | 22M | +14.94% |
Cormorant Asset Management, Lp | $64,816.00 | 8.47% | 1.69M | +823,219 | +94.62% | 2024-12-31 |
Blackrock, Inc. | $55,982.00 | 7.31% | 1.46M | +160,010 | +12.29% | 2024-12-31 |
Perceptive Advisors Llc | $50,902.00 | 6.65% | 1.33M | +165,700 | +14.23% | 2024-12-31 |
Price T Rowe Associates Inc /Md/ | $46,262.00 | 6.04% | 1.21M | +88,442 | +7.9% | 2024-12-31 |
Morgan Stanley | $44,540.00 | 5.82% | 1.16M | +1M | +1,345.37% | 2024-12-31 |
Vanguard Group Inc | $40,716.00 | 5.32% | 1.06M | +24,645 | +2.37% | 2024-12-31 |
Capital Research Global Investors | $38,034.00 | 4.97% | 993,569 | -3,525 | -0.35% | 2024-12-31 |
Vr Adviser, Llc | $37,897.00 | 4.95% | 989,985 | +283,854 | +40.2% | 2024-12-31 |
Janus Henderson Group Plc | $35,582.00 | 4.65% | 929,523 | +405,957 | +77.54% | 2024-12-31 |
State Street Corp | $29,424.00 | 3.84% | 768,655 | -20,969 | -2.66% | 2024-12-31 |